Luo S, Xie C, Lin N, Lin D, et al. Cost-effectiveness analysis of an orphan drug-tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing. Melanoma Res 2023 Aug 25. doi: 10.1097/CMR.0000000000000919.
PMID: 37650713